Related Experiment Video
Updated: Feb 11, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials
Jordi Diaz-Manera1,2, Roberto Fernandez-Torron3,4, Jaume LLauger5
1Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain.
Background And Objective:
Dysferlinopathies are a group of muscle disorders caused by mutations in the DYSF gene. Previous muscle imaging studies describe a selective pattern of muscle involvement in smaller patient cohorts, but a large imaging study across the entire spectrum of the dysferlinopathies had not been performed and previous imaging findings were not correlated with functional tests.
Methods:
We present cross-sectional T1-weighted muscle MRI data from 182 patients with genetically confirmed dysferlinopathies. We have analysed the pattern of muscles involved in the disease using hierarchical analysis and presented it as heatmaps. Results of the MRI scans have been correlated with relevant functional tests for each region of the body analysed.
Results:
In 181 of the 182 patients scanned, we observed muscle pathology on T1-weighted images, with the gastrocnemius medialis and the soleus being the most commonly affected muscles. A similar pattern of involvement was identified in most patients regardless of their clinical presentation. Increased muscle pathology on MRI correlated positively with disease duration and functional impairment.
Conclusions:
The information generated by this study is of high diagnostic value and important for clinical trial development. We have been able to describe a pattern that can be considered as characteristic of dysferlinopathy. We have defined the natural history of the disease from a radiological point of view. These results enabled the identification of the most relevant regions of interest for quantitative MRI in longitudinal studies, such as clinical trials.
Clinical Trial Registration:
NCT01676077.
Insights
Muscle MRI reveals a characteristic pattern in dysferlinopathies, with gastrocnemius medialis and soleus muscles most affected. This imaging approach aids diagnosis and clinical trial development for this genetic muscle disorder.
Area of Science:
- Neurology
- Radiology
- Genetics
Background:
- Dysferlinopathies are genetic muscle disorders caused by mutations in the DYSF gene.
- Previous muscle imaging studies were limited in scope and lacked correlation with functional tests.
Purpose of the Study:
- To perform a large-scale muscle MRI study across the spectrum of dysferlinopathies.
- To correlate imaging findings with functional tests.
- To establish a characteristic imaging pattern for diagnostic and clinical trial purposes.
Main Methods:
- Cross-sectional T1-weighted muscle MRI data from 182 genetically confirmed dysferlinopathy patients.
- Hierarchical analysis and heatmaps to analyze muscle involvement patterns.
- Correlation of MRI findings with relevant functional tests.
Main Results:
- Muscle pathology observed in 181/182 patients.
- Gastrocnemius medialis and soleus muscles were most frequently affected.
- Increased MRI pathology correlated with longer disease duration and greater functional impairment.
Conclusions:
- A characteristic muscle MRI pattern for dysferlinopathies was identified.
- Imaging findings provide diagnostic value and insights into disease natural history.
- Identified key regions of interest for quantitative MRI in future clinical trials.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Trial and Error and Algorithm
Fixed Action Patterns
Patterns of Fever

